Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9/1/21 16:38 | 8/30/21 | PIRS | Health | Drug | Pharmaceutical Preparations | Olwill Shane | MA | O | Chief De | S.d | -196 | 5.11 | 0 | -38 | -89 | 5 | D | ||||||||||||||
7/22/20 18:15 | 7/21/20 | PIRS | Health | Biolab | Commercial Physical & Biologi | Aquilo Capital Management, LLC | CA | T | S | -5,605 | 2.95 | 0 | -1,900 | -34 | 3,676 | I | |||||||||||||||
9/10/19 18:00 | 9/6/19 | PIRS | Financ | InvAdv | Investment Advice | Bvf Partners L P/il | CA | T | S.d | -225 | 4.50 | 0 | -50 | -14 | 314 | D | |||||||||||||||
5/2/18 17:13 | 4/30/18 | PIRS | Health | Biolab | Commercial Physical & Biologi | Orbimed Advisors LLC | NY | TH | See Rema | S | -6,350 | 6.35 | 0 | -1,000 | -96 | 39 | I | ||||||||||||||
2/15/18 16:57 | 2/13/18 | PIRS | Health | Biolab | Commercial Physical & Biologi | Orbimed Advisors LLC | NY | T | S.d | -71 | 8.98 | 0 | -8 | -14 | 49 | I | |||||||||||||||
1/4/18 15:23 | 1/3/18 | PIRS | Health | Biolab | Commercial Physical & Biologi | Orbimed Advisors LLC | NY | T | S | -12,566 | 7.35 | 0 | -1,710 | -97 | 49 | I | |||||||||||||||
12/20/17 17:12 | 12/18/17 | PIRS | Health | Biolab | Commercial Physical & Biologi | Orbimed Advisors LLC | NY | T | S.d | -842 | 5.70 | 0 | -148 | -69 | 65 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |